| Literature DB >> 31699177 |
Bronte McLeod1, Denny Meyer2, Greg Murray3, Fiona Foley4, Nev Jones5, Neil Thomas6.
Abstract
BACKGROUND: Mental health patients can experience involuntary treatment as disempowering and stigmatising, and contact with recovered peers is cited as important for countering stigma and fostering agency and autonomy integral to recovery. AIMS: To advance understanding of the interaction between involuntary treatment and contact with recovered peers, and explore hypothesised relationships to mechanisms of self-evaluation relevant to recovery.Entities:
Keywords: Peer contact; internalised stigma; involuntary treatment; personal recovery; serious mental illness
Year: 2019 PMID: 31699177 PMCID: PMC6854358 DOI: 10.1192/bjo.2019.72
Source DB: PubMed Journal: BJPsych Open ISSN: 2056-4724
Fig. 1Conceptual models illustrating hypothesised conditional direct and indirect effects for contact with recovered peers, involuntary treatment, internalised stigma, recovery-specific self-efficacy and recovery.
Summary of intercorrelations, means and standard deviations for involuntary treatment, contact with recovered peers, internalised stigma, self-efficacy for personal recovery and recovery
| 1 | 2 | 3 | 4 | 5 | |
|---|---|---|---|---|---|
| 1. Involuntary treatment | – | ||||
| 2. Contact with recovered peers | −0.224* | – | |||
| 3. Internalised stigma (ISMIS) | −0.040 | −0.123 | – | ||
| 4. Self-efficacy for personal recovery (SEPRS) | −0.050 | 0.060 | −0.454** | – | |
| 5. Recovery (QPR) | 0.043 | 0.123 | −0.308** | 0.649** | – |
| Mean | 0.54 | 0.37 | 68.45 | 65.04 | 56.71 |
| s.d. | 0.50 | 0.49 | 14.64 | 17.39 | 13.85 |
ISMIS, Internalised Stigma of Mental Illness Scale; SEPRS, Self-efficacy for Personal Recovery Scale; QPR, Questionnaire about the Process of Recovery.
Involuntary treatment; (0, no; 1, yes); contact with recovered peers (0, low; 1, high).
*P<0.05. **P<0.01.
Conditional process models
| Antecedent | Consequent | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Internalised stigma | Self-efficacy | Recovery | ||||||||||
| s.e. | s.e. | s.e. | ||||||||||
| Model 1 | ||||||||||||
| IT | −1.42 | 3.05 | −0.47 | 0.643 | ||||||||
| CRP | −3.65 | 2.92 | −1.25 | 0.216 | ||||||||
| IT × CRP (interaction term) | −13.26 | 5.84 | −2.27 | 0.026 | ||||||||
| Constant | 67.59 | 7.77 | 8.70 | <0.001 | ||||||||
| Symptom severity | −12.47 | 2.91 | −4.28 | <0.001 | ||||||||
| Psychiatric hospital admission | 19.23 | 5.5 | 3.49 | <0.001 | ||||||||
| Model 2 | ||||||||||||
| IT | −1.42 | 3.05 | −0.47 | 0.643 | −2.75 | 3.70 | −0.74 | 0.459 | ||||
| CRP | −3.65 | 2.92 | −1.25 | 0.216 | – | – | – | – | ||||
| IT × CRP (interaction term) | −13.26 | 5.84 | −2.27 | 0.026 | – | – | – | – | ||||
| Internalised stigma | – | – | – | – | −0.53 | 0.14 | −3.91 | <0.001 | ||||
| Constant | 67.59 | 7.77 | 8.70 | <0.001 | 104.06 | 13.32 | 7.81 | <0.001 | ||||
| Symptom severity | −12.47 | 2.91 | −4.28 | <0.001 | −1.84 | 4.08 | −0.45 | 0.653 | ||||
| Psychiatric hospital admission | 19.23 | 5.5 | 3.49 | <0.001 | 0.15 | 7.10 | 0.02 | 0.983 | ||||
| Model 3 | ||||||||||||
| IT | −1.42 | 3.05 | −0.47 | 0.643 | −2.75 | 3.7 | −0.74 | 0.459 | 0.75 | 2.31 | 0.32 | 0.747 |
| CRP | −3.65 | 2.92 | −1.25 | 0.216 | – | – | – | – | – | – | – | – |
| IT × CRP (interaction term) | −13.26 | 5.84 | −2.27 | 0.026 | – | – | – | – | – | – | – | – |
| Internalised stigma | – | – | – | – | −0.53 | 0.14 | −3.91 | <.001 | −0.02 | 0.09 | −0.26 | 0.798 |
| Self-efficacy | – | – | – | – | – | – | – | – | 0.51 | 0.07 | 7.44 | <0.001 |
| Constant | 67.59 | 7.77 | 8.70 | <0.001 | 104.06 | 13.32 | 7.81 | <0.001 | 33.17 | 10.91 | 3.04 | 0.003 |
| Symptom severity | −12.47 | 2.91 | −4.28 | <0.001 | −1.84 | 4.08 | −0.45 | 0.653 | 2.12 | 2.54 | 0.83 | 0.407 |
| Psychiatric hospital admission | 19.23 | 5.50 | 3.49 | <0.001 | 0.15 | 7.10 | 0.02 | 0.983 | −10.43 | 4.43 | −2.36 | 0.021 |
IT, involuntary treatment; CRP, contact with recovered peers.
n = 89. Unstandardised regression coefficients are reported. IT and CRP were mean-centred prior to analysis. In this model, only the effect of involuntary treatment on internalised stigma is moderated by contact with recovered peers. Bootstrap sample size, 5000.
Model 3 summary
| Conditional effects analyses | IT ➙ ISMIS | IT ➙ ISMIS ➙ SEPRS | IT ➙ ISMIS ➙ SEPRS ➙ QPR | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boot s.e. | BootLLCI | BootULCI | Summary | Boot s.e. | BootLLCI | BootULCI | Summary | Boot s.e. | BootLLCI | BootULCI | Summary | ||||
| Low CRP | 3.5 | 3.92 | 0.89 | 0.374 | −1.85 | 2.22 | −6.72 | 2.05 | −0.93 | 1.21 | −3.81 | 1.14 | |||
| High CRP | −9.76 | 4.52 | −2.16 | 0.034 | 5.15 | 2.57 | 0.6 | 10.63 | 2.61 | 1.43 | 0.22 | 5.84 | |||
IT, involuntary treatment; ISMIS, internalised stigma; SEPRS, self– efficacy; QPR, recovery; LLCI, lower limit confidence interval; UCIL, upper limit confidence interval; CRP, contact with recovered peers.
Bootstrap sample size, 5000. IT and CRP were mean-centred prior to analysis. In these models, only the effect of involuntary treatment on internalised stigma is moderated by contact with recovered peers.
Fig. 2Interaction effects on internalised stigma: contact with recovered peers significantly moderated the relationship between involuntary treatment experience and internalised stigma.